rs1260021106

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_ModerateBP6_Very_Strong

The NM_001354624.2(MLH1):​c.-28A>G variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000846 in 1,418,802 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.000015 ( 0 hom., cov: 29)
Exomes 𝑓: 0.0000078 ( 0 hom. )

Consequence

MLH1
NM_001354624.2 5_prime_UTR_premature_start_codon_gain

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -1.63

Publications

0 publications found
Variant links:
Genes affected
MLH1 (HGNC:7127): (mutL homolog 1) The protein encoded by this gene can heterodimerize with mismatch repair endonuclease PMS2 to form MutL alpha, part of the DNA mismatch repair system. When MutL alpha is bound by MutS beta and some accessory proteins, the PMS2 subunit of MutL alpha introduces a single-strand break near DNA mismatches, providing an entry point for exonuclease degradation. The encoded protein is also involved in DNA damage signaling and can heterodimerize with DNA mismatch repair protein MLH3 to form MutL gamma, which is involved in meiosis. This gene was identified as a locus frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). [provided by RefSeq, Aug 2017]
MLH1 Gene-Disease associations (from GenCC):
  • Lynch syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, G2P
  • Lynch syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp
  • Muir-Torre syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, G2P, Orphanet
  • mismatch repair cancer syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, G2P, ClinGen
  • Lynch syndrome 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • ovarian cancer
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • malignant pancreatic neoplasm
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • rhabdomyosarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • prostate cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • breast cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.07).
BP6
Variant 3-37025645-A-G is Benign according to our data. Variant chr3-37025645-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 483544.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001354624.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MLH1
NM_000249.4
MANE Select
c.1047A>Gp.Leu349Leu
synonymous
Exon 12 of 19NP_000240.1P40692-1
MLH1
NM_001354624.2
c.-28A>G
5_prime_UTR_premature_start_codon_gain
Exon 10 of 17NP_001341553.1
MLH1
NM_001354625.2
c.-28A>G
5_prime_UTR_premature_start_codon_gain
Exon 9 of 16NP_001341554.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MLH1
ENST00000231790.8
TSL:1 MANE Select
c.1047A>Gp.Leu349Leu
synonymous
Exon 12 of 19ENSP00000231790.3P40692-1
MLH1
ENST00000456676.7
TSL:1
c.1047A>Gp.Leu349Leu
synonymous
Exon 12 of 17ENSP00000416687.3H0Y818
MLH1
ENST00000413740.2
TSL:1
c.1047A>Gp.Leu349Leu
synonymous
Exon 12 of 15ENSP00000416476.2H0Y806

Frequencies

GnomAD3 genomes
AF:
0.0000151
AC:
2
AN:
132236
Hom.:
0
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000306
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00000777
AC:
10
AN:
1286566
Hom.:
0
Cov.:
31
AF XY:
0.0000126
AC XY:
8
AN XY:
634572
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
27974
American (AMR)
AF:
0.00
AC:
0
AN:
35120
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
22092
East Asian (EAS)
AF:
0.00
AC:
0
AN:
32502
South Asian (SAS)
AF:
0.00
AC:
0
AN:
55250
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
46988
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4696
European-Non Finnish (NFE)
AF:
0.00000891
AC:
9
AN:
1010168
Other (OTH)
AF:
0.0000193
AC:
1
AN:
51776
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.430
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000151
AC:
2
AN:
132236
Hom.:
0
Cov.:
29
AF XY:
0.00
AC XY:
0
AN XY:
62842
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33128
American (AMR)
AF:
0.00
AC:
0
AN:
11816
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3390
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4458
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4320
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6994
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
180
European-Non Finnish (NFE)
AF:
0.0000306
AC:
2
AN:
65338
Other (OTH)
AF:
0.00
AC:
0
AN:
1718
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.625
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
Hereditary cancer-predisposing syndrome (2)
-
-
1
Colorectal cancer, hereditary nonpolyposis, type 2 (1)
-
-
1
Hereditary nonpolyposis colorectal neoplasms (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.76
CADD
Benign
1.5
DANN
Benign
0.55
PhyloP100
-1.6
PromoterAI
0.0074
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1260021106; hg19: chr3-37067136; API